Literature DB >> 33680451

Analysis of SLC7A9 gene mutations among Jordanian patients with cystinuria.

Omar M Halalsheh1, Mustafa A Al-Shehabat2, Moh''D A Al-Ghazo1, Ibrahim F Al-Ghalayini1, Yaman A Altal1, Radwan Al-Okour1, Omar Altal3.   

Abstract

BACKGROUND: Cystinuria is known as a heritable disorder affecting the cysteine reabsorption by renal system as well as the reabsorption of dibasic amino acids. The main objectives of the present study were to identify genetic mutations in SLC7A9 gene associated with cystinuria.
METHODS: A cross sectional study design was conducted. A total of 28 patients diagnosed with cystinuria were included. Molecular techniques were applied to identify genetic mutations in SLC7A9 gene.
RESULTS: The mean age of study participants was 31.57 ± 2.88 years, and slightly more than two thirds of participants were males. Mutations of SLC 7A9 gene showed that the majority of cases (57.1%) were homogeneous, (7.1%) heterogeneous, and slightly more than one third of patients had no mutations. There was no statistically significant relationship between mutations for the SLC7A9 gene and gender (p = 0.249).
CONCLUSION: Mutations in the SLC7A9 gene are prevalent and can be used as molecular tools to diagnose cystinuria.
© 2021 The Authors.

Entities:  

Keywords:  Cystinuria; Gene; Mutations; SLC7A9

Year:  2021        PMID: 33680451      PMCID: PMC7930589          DOI: 10.1016/j.amsu.2021.102182

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  18 in total

1.  Heterogeneous mutations in the SLC3A1 and SLC7A9 genes in Chinese patients with cystinuria.

Authors:  Y-P Yuen; C-W Lam; C-K Lai; S-F Tong; P-S Li; S Tam; E Y-W Kwan; S-Y Chan; W-K Tsang; K-Y Chan; W-L Mak; C-W Cheng; Y-W Chan
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 2.  Aminoacidurias: Clinical and molecular aspects.

Authors:  S M R Camargo; D Bockenhauer; R Kleta
Journal:  Kidney Int       Date:  2008-01-16       Impact factor: 10.612

Review 3.  The renal handling of amino acids and oligopeptides.

Authors:  S Silbernagl
Journal:  Physiol Rev       Date:  1988-07       Impact factor: 37.312

4.  Identification of 12 novel mutations in the SLC3A1 gene in Swedish cystinuria patients.

Authors:  L Harnevik; E Fjellstedt; A Molbaek; H G Tiselius; T Denneberg; P Söderkvist
Journal:  Hum Mutat       Date:  2001-12       Impact factor: 4.878

5.  STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery.

Authors:  Riaz Agha; Ali Abdall-Razak; Eleanor Crossley; Naeem Dowlut; Christos Iosifidis; Ginimol Mathew
Journal:  Int J Surg       Date:  2019-11-06       Impact factor: 6.071

Review 6.  Pathophysiology and treatment of cystinuria.

Authors:  Josep Chillarón; Mariona Font-Llitjós; Joana Fort; Antonio Zorzano; David S Goldfarb; Virginia Nunes; Manuel Palacín
Journal:  Nat Rev Nephrol       Date:  2010-06-01       Impact factor: 28.314

7.  Cloning and chromosomal localization of a human kidney cDNA involved in cystine, dibasic, and neutral amino acid transport.

Authors:  W S Lee; R G Wells; R V Sabbag; T K Mohandas; M A Hediger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Mutations in the genomic deoxyribonucleic acid for SLC3A1 in patients with cystinuria.

Authors:  W L Gitomer; B Y Reed; L A Ruml; K Sakhaee; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

9.  The value of family screening for patients with cystine stone disease in northern Jordan.

Authors:  I Bani Hani; Y Matani; I Smadi
Journal:  Br J Urol       Date:  1998-05

10.  Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification.

Authors:  Luca Dello Strologo; Elon Pras; Claudia Pontesilli; Ercole Beccia; Vittorino Ricci-Barbini; Luisa de Sanctis; Alberto Ponzone; Michele Gallucci; Luigi Bisceglia; Leopoldo Zelante; Maite Jimenez-Vidal; Mariona Font; Antonio Zorzano; Ferran Rousaud; Virginia Nunes; Paolo Gasparini; Manuel Palacín; Gianfranco Rizzoni
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.